A Study of Definitive Therapy to Treat Prostate Cancer

NCT02716974 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Leuprolide Acetate
DRUG: Bicalutamide
DRUG: Docetaxel
PROCEDURE: Prostatectomy
RADIATION: Radiation

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins